Tuberculosis Vaccine Treatment Industry Research Report 2023
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-GuŠ¹rin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
Highlights
The global Tuberculosis Vaccine Treatment market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccine Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccine Treatment.
The Tuberculosis Vaccine Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tuberculosis Vaccine Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccine Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Tuberculosis Vaccine Treatment type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Tuberculosis Vaccine Treatment are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Tuberculosis Vaccine Treatment segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Tuberculosis Vaccine Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Tuberculosis Vaccine Treatment market.
Tuberculosis Vaccine Treatment segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Tuberculosis Vaccine Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccine Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccine Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Tuberculosis Vaccine Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccine Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tuberculosis Vaccine Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tuberculosis Vaccine Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tuberculosis Vaccine Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
Highlights
The global Tuberculosis Vaccine Treatment market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Vaccine Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Vaccine Treatment.
The Tuberculosis Vaccine Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Tuberculosis Vaccine Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tuberculosis Vaccine Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC
- Queen Saovabha Mem. Inst
- Microgen
Global markets are presented by Tuberculosis Vaccine Treatment type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Tuberculosis Vaccine Treatment are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Tuberculosis Vaccine Treatment segment by Type
- Immune Vaccine
- Therapy Vaccine
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Tuberculosis Vaccine Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Tuberculosis Vaccine Treatment market.
Tuberculosis Vaccine Treatment segment by Application
- Self-Procurement
- UNICEF
- Other
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Tuberculosis Vaccine Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccine Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccine Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Tuberculosis Vaccine Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccine Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tuberculosis Vaccine Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tuberculosis Vaccine Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tuberculosis Vaccine Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Tuberculosis Vaccine Treatment Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Tuberculosis Vaccine Treatment Sales (K Dose) of Manufacturers (2018-2023)
Table 7. Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Tuberculosis Vaccine Treatment Revenue of Manufacturers (2018-2023)
Table 9. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Tuberculosis Vaccine Treatment Average Price (USD/K Dose) of Manufacturers (2018-2023)
Table 11. Global Tuberculosis Vaccine Treatment Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Tuberculosis Vaccine Treatment, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Vaccine Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merck Company Information
Table 17. Merck Business Overview
Table 18. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 19. Merck Tuberculosis Vaccine Treatment Product Portfolio
Table 20. Merck Recent Developments
Table 21. Japan BCG Lab Company Information
Table 22. Japan BCG Lab Business Overview
Table 23. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 24. Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio
Table 25. Japan BCG Lab Recent Developments
Table 26. Serum Institute of India Company Information
Table 27. Serum Institute of India Business Overview
Table 28. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 29. Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio
Table 30. Serum Institute of India Recent Developments
Table 31. AJ Vaccines Company Information
Table 32. AJ Vaccines Business Overview
Table 33. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 34. AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio
Table 35. AJ Vaccines Recent Developments
Table 36. BioFarma Company Information
Table 37. BioFarma Business Overview
Table 38. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 39. BioFarma Tuberculosis Vaccine Treatment Product Portfolio
Table 40. BioFarma Recent Developments
Table 41. GreenSignal Bio Pharma Company Information
Table 42. GreenSignal Bio Pharma Business Overview
Table 43. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 44. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio
Table 45. GreenSignal Bio Pharma Recent Developments
Table 46. China National Biotec Company Information
Table 47. China National Biotec Business Overview
Table 48. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 49. China National Biotec Tuberculosis Vaccine Treatment Product Portfolio
Table 50. China National Biotec Recent Developments
Table 51. Biomed Lublin Company Information
Table 52. Biomed Lublin Business Overview
Table 53. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 54. Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio
Table 55. Biomed Lublin Recent Developments
Table 56. Taj Pharmaceuticals Company Information
Table 57. Taj Pharmaceuticals Business Overview
Table 58. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 59. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio
Table 60. Taj Pharmaceuticals Recent Developments
Table 61. Ataulpho de Paiva Company Information
Table 62. Ataulpho de Paiva Business Overview
Table 63. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 64. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio
Table 65. Ataulpho de Paiva Recent Developments
Table 66. IVAC Company Information
Table 67. IVAC Business Overview
Table 68. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 69. IVAC Tuberculosis Vaccine Treatment Product Portfolio
Table 70. IVAC Recent Developments
Table 71. Queen Saovabha Mem. Inst Company Information
Table 72. Queen Saovabha Mem. Inst Business Overview
Table 73. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 74. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio
Table 75. Queen Saovabha Mem. Inst Recent Developments
Table 76. Microgen Company Information
Table 77. Microgen Business Overview
Table 78. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 79. Microgen Tuberculosis Vaccine Treatment Product Portfolio
Table 80. Microgen Recent Developments
Table 81. Global Tuberculosis Vaccine Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 82. Global Tuberculosis Vaccine Treatment Sales by Region (2018-2023) & (K Dose)
Table 83. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2018-2023)
Table 84. Global Tuberculosis Vaccine Treatment Sales by Region (2024-2029) & (K Dose)
Table 85. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2024-2029)
Table 86. Global Tuberculosis Vaccine Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 87. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2018-2023)
Table 88. Global Tuberculosis Vaccine Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 89. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2024-2029)
Table 90. North America Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. North America Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 92. North America Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 93. North America Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 94. North America Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 95. Europe Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Europe Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 97. Europe Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 98. Europe Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 99. Europe Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 100. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Asia Pacific Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 102. Asia Pacific Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 103. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 104. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 105. Latin America Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Latin America Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 107. Latin America Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 108. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 109. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 112. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 113. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 115. Global Tuberculosis Vaccine Treatment Sales by Type (2018-2023) & (K Dose)
Table 116. Global Tuberculosis Vaccine Treatment Sales by Type (2024-2029) & (K Dose)
Table 117. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2018-2023)
Table 118. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2024-2029)
Table 119. Global Tuberculosis Vaccine Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 120. Global Tuberculosis Vaccine Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 121. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2018-2023)
Table 122. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2024-2029)
Table 123. Global Tuberculosis Vaccine Treatment Price by Type (2018-2023) & (USD/K Dose)
Table 124. Global Tuberculosis Vaccine Treatment Price by Type (2024-2029) & (USD/K Dose)
Table 125. Global Tuberculosis Vaccine Treatment Sales by Application (2018-2023) & (K Dose)
Table 126. Global Tuberculosis Vaccine Treatment Sales by Application (2024-2029) & (K Dose)
Table 127. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2018-2023)
Table 128. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2024-2029)
Table 129. Global Tuberculosis Vaccine Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 130. Global Tuberculosis Vaccine Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 131. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2018-2023)
Table 132. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2024-2029)
Table 133. Global Tuberculosis Vaccine Treatment Price by Application (2018-2023) & (USD/K Dose)
Table 134. Global Tuberculosis Vaccine Treatment Price by Application (2024-2029) & (USD/K Dose)
Table 135. Key Raw Materials
Table 136. Raw Materials Key Suppliers
Table 137. Tuberculosis Vaccine Treatment Distributors List
Table 138. Tuberculosis Vaccine Treatment Customers List
Table 139. Tuberculosis Vaccine Treatment Industry Trends
Table 140. Tuberculosis Vaccine Treatment Industry Drivers
Table 141. Tuberculosis Vaccine Treatment Industry Restraints
Table 142. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Tuberculosis Vaccine Treatment Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Tuberculosis Vaccine Treatment Sales (K Dose) of Manufacturers (2018-2023)
Table 7. Global Tuberculosis Vaccine Treatment Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Tuberculosis Vaccine Treatment Revenue of Manufacturers (2018-2023)
Table 9. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Tuberculosis Vaccine Treatment Average Price (USD/K Dose) of Manufacturers (2018-2023)
Table 11. Global Tuberculosis Vaccine Treatment Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Tuberculosis Vaccine Treatment, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tuberculosis Vaccine Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Merck Company Information
Table 17. Merck Business Overview
Table 18. Merck Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 19. Merck Tuberculosis Vaccine Treatment Product Portfolio
Table 20. Merck Recent Developments
Table 21. Japan BCG Lab Company Information
Table 22. Japan BCG Lab Business Overview
Table 23. Japan BCG Lab Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 24. Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolio
Table 25. Japan BCG Lab Recent Developments
Table 26. Serum Institute of India Company Information
Table 27. Serum Institute of India Business Overview
Table 28. Serum Institute of India Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 29. Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolio
Table 30. Serum Institute of India Recent Developments
Table 31. AJ Vaccines Company Information
Table 32. AJ Vaccines Business Overview
Table 33. AJ Vaccines Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 34. AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolio
Table 35. AJ Vaccines Recent Developments
Table 36. BioFarma Company Information
Table 37. BioFarma Business Overview
Table 38. BioFarma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 39. BioFarma Tuberculosis Vaccine Treatment Product Portfolio
Table 40. BioFarma Recent Developments
Table 41. GreenSignal Bio Pharma Company Information
Table 42. GreenSignal Bio Pharma Business Overview
Table 43. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 44. GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolio
Table 45. GreenSignal Bio Pharma Recent Developments
Table 46. China National Biotec Company Information
Table 47. China National Biotec Business Overview
Table 48. China National Biotec Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 49. China National Biotec Tuberculosis Vaccine Treatment Product Portfolio
Table 50. China National Biotec Recent Developments
Table 51. Biomed Lublin Company Information
Table 52. Biomed Lublin Business Overview
Table 53. Biomed Lublin Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 54. Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolio
Table 55. Biomed Lublin Recent Developments
Table 56. Taj Pharmaceuticals Company Information
Table 57. Taj Pharmaceuticals Business Overview
Table 58. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 59. Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolio
Table 60. Taj Pharmaceuticals Recent Developments
Table 61. Ataulpho de Paiva Company Information
Table 62. Ataulpho de Paiva Business Overview
Table 63. Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 64. Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolio
Table 65. Ataulpho de Paiva Recent Developments
Table 66. IVAC Company Information
Table 67. IVAC Business Overview
Table 68. IVAC Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 69. IVAC Tuberculosis Vaccine Treatment Product Portfolio
Table 70. IVAC Recent Developments
Table 71. Queen Saovabha Mem. Inst Company Information
Table 72. Queen Saovabha Mem. Inst Business Overview
Table 73. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 74. Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolio
Table 75. Queen Saovabha Mem. Inst Recent Developments
Table 76. Microgen Company Information
Table 77. Microgen Business Overview
Table 78. Microgen Tuberculosis Vaccine Treatment Sales (K Dose), Revenue (US$ Million), Price (USD/K Dose) and Gross Margin (2018-2023)
Table 79. Microgen Tuberculosis Vaccine Treatment Product Portfolio
Table 80. Microgen Recent Developments
Table 81. Global Tuberculosis Vaccine Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 82. Global Tuberculosis Vaccine Treatment Sales by Region (2018-2023) & (K Dose)
Table 83. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2018-2023)
Table 84. Global Tuberculosis Vaccine Treatment Sales by Region (2024-2029) & (K Dose)
Table 85. Global Tuberculosis Vaccine Treatment Sales Market Share by Region (2024-2029)
Table 86. Global Tuberculosis Vaccine Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 87. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2018-2023)
Table 88. Global Tuberculosis Vaccine Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 89. Global Tuberculosis Vaccine Treatment Revenue Market Share by Region (2024-2029)
Table 90. North America Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. North America Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 92. North America Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 93. North America Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 94. North America Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 95. Europe Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Europe Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 97. Europe Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 98. Europe Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 99. Europe Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 100. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Asia Pacific Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 102. Asia Pacific Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 103. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 104. Asia Pacific Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 105. Latin America Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Latin America Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 107. Latin America Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 108. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 109. Latin America Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2018-2023) & (K Dose)
Table 112. Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2024-2029) & (K Dose)
Table 113. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 115. Global Tuberculosis Vaccine Treatment Sales by Type (2018-2023) & (K Dose)
Table 116. Global Tuberculosis Vaccine Treatment Sales by Type (2024-2029) & (K Dose)
Table 117. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2018-2023)
Table 118. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2024-2029)
Table 119. Global Tuberculosis Vaccine Treatment Revenue by Type (2018-2023) & (US$ Million)
Table 120. Global Tuberculosis Vaccine Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 121. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2018-2023)
Table 122. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2024-2029)
Table 123. Global Tuberculosis Vaccine Treatment Price by Type (2018-2023) & (USD/K Dose)
Table 124. Global Tuberculosis Vaccine Treatment Price by Type (2024-2029) & (USD/K Dose)
Table 125. Global Tuberculosis Vaccine Treatment Sales by Application (2018-2023) & (K Dose)
Table 126. Global Tuberculosis Vaccine Treatment Sales by Application (2024-2029) & (K Dose)
Table 127. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2018-2023)
Table 128. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2024-2029)
Table 129. Global Tuberculosis Vaccine Treatment Revenue by Application (2018-2023) & (US$ Million)
Table 130. Global Tuberculosis Vaccine Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 131. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2018-2023)
Table 132. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2024-2029)
Table 133. Global Tuberculosis Vaccine Treatment Price by Application (2018-2023) & (USD/K Dose)
Table 134. Global Tuberculosis Vaccine Treatment Price by Application (2024-2029) & (USD/K Dose)
Table 135. Key Raw Materials
Table 136. Raw Materials Key Suppliers
Table 137. Tuberculosis Vaccine Treatment Distributors List
Table 138. Tuberculosis Vaccine Treatment Customers List
Table 139. Tuberculosis Vaccine Treatment Industry Trends
Table 140. Tuberculosis Vaccine Treatment Industry Drivers
Table 141. Tuberculosis Vaccine Treatment Industry Restraints
Table 142. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Tuberculosis Vaccine TreatmentProduct Picture
Figure 5. Global Tuberculosis Vaccine Treatment Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Tuberculosis Vaccine Treatment Market Size (2018-2029) & (US$ Million)
Figure 7. Global Tuberculosis Vaccine Treatment Sales (2018-2029) & (K Dose)
Figure 8. Global Tuberculosis Vaccine Treatment Average Price (USD/K Dose) & (2018-2029)
Figure 9. Immune Vaccine Product Picture
Figure 10. Therapy Vaccine Product Picture
Figure 11. Self-Procurement Product Picture
Figure 12. UNICEF Product Picture
Figure 13. Other Product Picture
Figure 14. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Tuberculosis Vaccine Treatment, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Tuberculosis Vaccine Treatment, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Tuberculosis Vaccine Treatment Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Tuberculosis Vaccine Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Tuberculosis Vaccine Treatment Sales by Region in 2022
Figure 21. Global Tuberculosis Vaccine Treatment Revenue by Region in 2022
Figure 22. North America Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 23. North America Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 24. North America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 25. United States Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 28. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 29. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 30. Germany Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 36. Asia Pacific Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 38. China Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 48. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 49. Latin America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 54. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2018-2029)
Figure 60. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2018-2029)
Figure 61. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Type (2018-2029)
Figure 62. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2018-2029)
Figure 63. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2018-2029)
Figure 64. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Application (2018-2029)
Figure 65. Tuberculosis Vaccine Treatment Value Chain
Figure 66. Tuberculosis Vaccine Treatment Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Tuberculosis Vaccine Treatment Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Tuberculosis Vaccine TreatmentProduct Picture
Figure 5. Global Tuberculosis Vaccine Treatment Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Tuberculosis Vaccine Treatment Market Size (2018-2029) & (US$ Million)
Figure 7. Global Tuberculosis Vaccine Treatment Sales (2018-2029) & (K Dose)
Figure 8. Global Tuberculosis Vaccine Treatment Average Price (USD/K Dose) & (2018-2029)
Figure 9. Immune Vaccine Product Picture
Figure 10. Therapy Vaccine Product Picture
Figure 11. Self-Procurement Product Picture
Figure 12. UNICEF Product Picture
Figure 13. Other Product Picture
Figure 14. Global Tuberculosis Vaccine Treatment Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Tuberculosis Vaccine Treatment, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Tuberculosis Vaccine Treatment, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Tuberculosis Vaccine Treatment Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Tuberculosis Vaccine Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Tuberculosis Vaccine Treatment Sales by Region in 2022
Figure 21. Global Tuberculosis Vaccine Treatment Revenue by Region in 2022
Figure 22. North America Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 23. North America Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 24. North America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 25. United States Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 28. Europe Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 29. Europe Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 30. Germany Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 36. Asia Pacific Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 38. China Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 48. Latin America Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 49. Latin America Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country in 2022
Figure 54. Middle East and Africa Tuberculosis Vaccine Treatment Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Tuberculosis Vaccine Treatment Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Tuberculosis Vaccine Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2018-2029)
Figure 60. Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2018-2029)
Figure 61. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Type (2018-2029)
Figure 62. Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2018-2029)
Figure 63. Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2018-2029)
Figure 64. Global Tuberculosis Vaccine Treatment Price (USD/K Dose) by Application (2018-2029)
Figure 65. Tuberculosis Vaccine Treatment Value Chain
Figure 66. Tuberculosis Vaccine Treatment Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Tuberculosis Vaccine Treatment Industry Opportunities and Challenges
